Roquefort Therapeutics PLC Sustainability Reports
A clinical-stage oncology company focused on developing precision medicines and therapies for cancer. It advances pre-clinical and clinical drug development pipelines targeting historically complex oncogenic proteins.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange
LEI: 254900P4SISIWOR9RH34
3 reports from 2021 to 2024